Frontiers in Pharmacology | Inflammation Pharmacology

Original Research

Published on 02 Aug 2023

As an inhibitor of norepinephrine release, dexmedetomidine provides no improvement on stroke-associated pneumonia in mice

in Inflammation Pharmacology

Miaomiao Zhou
Qiong Luo
Younian Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1203646

2,594 views
2 citations

Review

Published on 01 Aug 2023

The applications of functional materials-based nano-formulations in the prevention, diagnosis and treatment of chronic inflammation-related diseases

in Inflammation Pharmacology

Jingjing Wang
Rui Ni
Tingting Jiang
Dan Peng
Yue Ming
Hongjuan Cui
Yao Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1222642

4,160 views
1 citation

Original Research

Published on 01 Aug 2023

Salvianolic acid B attenuates inflammation and prevent pathologic fibrosis by inhibiting CD36-mediated activation of the PI3K-Akt signaling pathway in frozen shoulder

in Inflammation Pharmacology

Yan Yan
Min Zhou
Ke Meng
Chuanhai Zhou
Xiaoyu Jia
Xinhao Li
Dedong Cui
Menglei Yu
Yiyong Tang
Ming Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1230174

4,281 views
12 citations

Original Research

Published on 28 Jul 2023

Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation

in Inflammation Pharmacology

Jing Lu
Jie Gao
Jing Sun
Haiping Wang
Huijuan Sun
Qian Huang
Yao Zhang
Shuo Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1106339

3,028 views
6 citations

Review

Published on 27 Jul 2023

Immunometabolism changes in fibrosis: from mechanisms to therapeutic strategies

in Inflammation Pharmacology

Lixiang Feng
Xingyu Chen
Yujing Huang
Xiaodian Zhang
Shaojiang Zheng
Na Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1243675

4,321 views
8 citations

Original Research

Published on 25 Jul 2023

Cryptotanshinone affects HFL-1 cells proliferation by inhibiting cytokines secretion in RAW264.7 cells and ameliorates inflammation and fibrosis in newborn rats with hyperoxia induced lung injury

in Inflammation Pharmacology

Mengmeng Ma
Tianping Bao
Jingyan Li
Linxia Cao
Bingrui Yu
Jingjing Hu
Huaiping Cheng
Zhaofang Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1192370

2,749 views
3 citations

Original Research

Published on 21 Jul 2023

Ursolic acid reduces oxidative stress injury to ameliorate experimental autoimmune myocarditis by activating Nrf2/HO-1 signaling pathway

in Inflammation Pharmacology

Yanan Fu
Tianshu Liu
Shukun He
Yichan Zhang
Yuting Tan
Ying Bai
Jiawei Shi
Wenhui Deng
Jiani Qiu
Zhen Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1189372

4,748 views
10 citations

Review

Published on 21 Jul 2023

Advances of the small molecule drugs regulating fibroblast-like synovial proliferation for rheumatoid arthritis

in Inflammation Pharmacology

Yitong Tong
Xinyu Li
Qichuan Deng
Jianyou Shi
Yibin Feng
Lan Bai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1230293

6,481 views
20 citations

Original Research

Published on 20 Jul 2023

A sustained-release phospholipid-based phase separation gel loaded with berberine for treating rheumatoid arthritis

in Inflammation Pharmacology

Xiong Peng
Yuping Yang
Chenqi Guo
Qin He
Yan Li
Tao Gong
Jia Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1210129

4,869 views
5 citations

Original Research

Published on 19 Jul 2023

18-α-glycyrrhetinic acid alleviates oxidative damage in periodontal tissue by modulating the interaction of Cx43 and JNK/NF-κB pathways

in Inflammation Pharmacology

Niuben Cao
Xiaomeng Liu
Yubo Hou
Yu Deng
Yu Xin
Xirui Xin
Xinchen Xiang
Xinchan Liu
Weixian Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1221053

2,682 views
9 citations

Original Research

Published on 11 Jul 2023

Integration analysis of senescence-related genes to predict prognosis and immunotherapy response in soft-tissue sarcoma: evidence based on machine learning and experiments

in Inflammation Pharmacology

Lin Qi
Fangyue Chen
Lu Wang
Zhimin Yang
Wenchao Zhang
Zhihong Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1229233

3,111 views
3 citations

Editorial

Published on 03 Jul 2023

Editorial: The challenges of drug repurposing in diseases related to chronic inflammation

in Inflammation Pharmacology

Debora Collotta
Laura Lucarini

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1242880

1,649 views
1 citation

Original Research

Published on 26 Jun 2023

HECT, UBA and WWE domain containing 1 represses cholesterol efflux during CD4+ T cell activation in Sjögren’s syndrome

in Inflammation Pharmacology

Junhao Yin
Jiabao Xu
Changyu Chen
Xinyi Ma
Hanyi Zhu
Lisong Xie
Baoli Wang
Yanxiong Shao
Yijie Zhao
Yu Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1191692

4,350 views
5 citations

Review

Published on 15 Jun 2023

Autophagy in intestinal fibrosis: relevance in inflammatory bowel disease

in Inflammation Pharmacology

Dulce C. Macias-Ceja
María D. Barrachina
Dolores Ortiz-Masià

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1170436

3,864 views
4 citations

Editorial

Published on 14 Jun 2023

Editorial: Eicosanoids in cancer, Volume II

in Inflammation Pharmacology

Paola Patrignani
Emer M. Smyth
Emanuela Ricciotti

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1224623

1,399 views
2 citations

Editorial

Published on 13 Jun 2023

Editorial: Pharmacology of autoimmune and neuroinflammatory disease from a preclinical and clinical perspective

in Inflammation Pharmacology

Martin Šíma
Andrea Laslop
John Joseph Borg
Silvester Poništ
Daniela Melchiorri
František Dráfi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1228406

1,893 views